EPIDEMIOLOGICAL AND CLINICOPATHOLOGICAL PROFILE AND TREATMENT OUTCOME OF COLON CANCER IN A TERTIARY CARE CENTRE A RETROSPECTIVE ANALYSIS

Main Article Content

Arth Shah
Hemendra Mishra
Rajesh Patidar
Vikas Asati
Archit Jain
Anirudh Singh
Astha Parmar
Col. P.G Chitalkar

Keywords

Colon cancer, epidemiology, clinicopathology, carcinoembryonic antigen

Abstract

Background: Colon cancer is an emerging health concern in India, with limited data on its epidemiological and clinicopathological characteristics. This study aimed to analyze the demographic profile, clinical features, pathological findings, and treatment outcomes of colon cancer patients managed at a tertiary care center.


Methods: A retrospective observational study was conducted on 43 patients diagnosed with colon cancer. Demographic, clinical, histopathological, and treatment-related data were collected from hospital records. Statistical analysis was performed using SPSS version 26.0, and variables were compared using appropriate tests, with p < 0.05 considered significant.


Results: The mean age of patients was 51.5 years, with most cases occurring in the 41–60 year age group. Males constituted 55.8% of the cohort. Family history of malignancy was rare (2.3%). The ascending colon/hepatic flexure and sigmoid colon were the most frequent sites of involvement. Abdominal pain was the predominant symptom (95.3%), followed by altered bowel habits (53.5%), weight loss (48.8%), and anemia (30.2%). Adenocarcinoma was the most common histological subtype (93%). More than half of the patients (51.2%) presented with stage IV disease, with frequent metastases to the peritoneum (59.1%), lymph nodes (54.5%), and liver (22.7%). Mean baseline CEA was 130.7 ng/mL, with extreme elevations in a subset of patients. Treatment intent was nearly equally divided between curative (48.8%) and palliative (51.2%).


Conclusion: Colon cancer in this cohort primarily affected middle-aged adults, was mostly sporadic, and commonly presented at advanced stages with a high metastatic burden. These findings highlight the urgent need for early detection, routine screening, and integration of molecular profiling to improve outcomes in Indian patients.

Abstract 19 | Pdf Downloads 1

References

1. Sehrawat A, Khanna M, Kayal S, Sundriyal D, Tiwari S, Cyriac S et al. Clinicopathologic Profile and Treatment Outcomes of Colorectal Cancer in Young Adults: A Multicenter Study From India. JCO Glob Oncol. 2024 May;10:e2300225.
2. Lukman K, Muhammad A, Ghozali M, Nugraha P. Epidemiological and clinicopathological characteristics of colorectal cancer patients in a tertiary hospital in West Java. Clin Epidemiol Glob Health. 2024 Jul;28(2):101688.
3. ICMR-NCDIR: National Noncommunicable Disease Monitoring Survey (NNMS) 2017-18. Bengaluru, India
4. Sodergren SC, Husson O, Robinson J, Rohde GE, Tomaszewska IM, Vivat B, Dyar R, Darlington AS; EORTC Quality of Life Group. Systematic review of the health-related quality of life issues facing adolescents and young adults with cancer. Qual Life Res. 2017 Jul;26(7):1659-1672.
5. The Lancet Gastroenterology Hepatology. Addressing the rise of early-onset colorectal cancer. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):197.
6. Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, Jemal A. Colorectal Cancer Incidence Patterns in the United States, 1974-2013. J Natl Cancer Inst. 2017 Aug 1;109(8):djw322.
7. Levine OH, Zbuk KM, Bleyer A. Topographical incidence and survival analysis of gastrointestinal tract cancer in adolescent and young adults compared with older adults in the United States. J Clin Oncol. 2017 Feb;35(4_suppl):545.
8. GBD 2019 Adolescent Young Adult Cancer Collaborators. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Oncol. 2022 Jan;23(1):27-52.
9. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
10. Patil PS, Saklani A, Gambhire P, et al. Colorectal cancer in India: An audit from a tertiary center in a low prevalence area. Indian J Surg Oncol. 2017;8(4):484–490.
11. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–103.
12. Favoriti P, Carbone G, Greco M, et al. Worldwide burden of colorectal cancer: a review. Updates Surg. 2016;68(1):7–11.
13. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348(10):919–932.
14. Gervaz P, Bucher P, Morel P. Two colons—two cancers: paradigm shift and clinical implications. J Surg Oncol. 2004;88(4):261–266.
15. Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691.
16. Benedix F, Kube R, Meyer F, et al. Comparison of left- and right-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum. 2010;53(1):57–64.
17. Shamim G, Parvez S, Malhotra AS, Qadri NM, Muzaffar M, Taban N, Khajuria A. Colorectal carcinoma in India: A study from a tertiary care centre. IP J Diagn Pathol Oncol. 2024;9(2):111-115.
18. Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal Cancer: Epidemiology, Risk Factors, and Prevention. Cancers (Basel). 2024 Apr 17;16(8):1530.
19. O’Connell JB, et al. Colorectal carcinoma in the young: an analysis of 13,794 patients from the National Cancer Database. Cancer. 2004;101(3):485–495.
20. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. WHO Classification of Tumours. IARC Press, Lyon; 2000.
21. Sung CO, Seo JW, Kim KM, Do IG, Kim SW, Park CK. Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma. Mod Pathol. 2008 Dec;21(12):1533-41.
22. Patil PS, Saklani A, Gambhire P, Mehta S, Engineer R, De'Souza A, Chopra S, Bal M. Colorectal Cancer in India: An Audit from a Tertiary Center in a Low Prevalence Area. Indian J Surg Oncol. 2017 Dec;8(4):484-490.
23. Sharma D, Singh G. Clinico-pathological profile of colorectal cancer in first two decades of life: A retrospective analysis from tertiary health center. Indian J Cancer. 2017 Apr-Jun;54(2):397-400.
24. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017 May 6;67(3):177-193.
25. Behbehani AI, Al-Sayer H, Farghaly M, Kanawati N, Mathew A, al-Bader A, Van Dalen A. Prognostic significance of CEA and CA 19-9 in colorectal cancer in Kuwait. Int J Biol Markers. 2000 Jan-Mar;15(1):51-5.
26. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138(6):2073–2087.
27. Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015 Nov;21(11):1350-6.
28. Mohandas KM, Desai DC. Epidemiology of digestive tract cancers in India. Indian J Gastroenterol. 1999;18(3):118–121.

Most read articles by the same author(s)